Combination ADI-PEG 20, TMZ, and RT for Treatment of Newly Diagnosed High-grade Glioma (HGG)

Clinical trial NCT07389278 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07389278
Sponsor: Sabine Mueller, MD, PhD
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Glioblastoma High-Grade Glioma (WHO III-IV)High-grade Glioma Diffuse Midline Glioma, H3 K27M-Mutant Diffuse Hemispheric Glioma, H3G34 Mutant

Start date: 2026-03-09
Primary completion: 2032-06-30
Enrollment: 97

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.